No Data
No Data
Citi's North America Focus List Updated, Adds: Coca-Cola, Evergy, Etc.
Express News | IDEAYA Biosciences Inc : JP Morgan Raises Target Price to $65 From $55
Stifel Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Raises Target Price to $63
Stifel analyst Benjamin Burnett maintains $IDEAYA Biosciences(IDYA.US)$ with a buy rating, and adjusts the target price from $55 to $63.According to TipRanks data, the analyst has a success rate of 35
A Quick Look at Today's Ratings for IDEAYA Biosciences(IDYA.US), With a Forecast Between $50 to $63
On Jun 04, major Wall Street analysts update their ratings for $IDEAYA Biosciences(IDYA.US)$, with price targets ranging from $50 to $63.J.P. Morgan analyst Anupam Rama maintains with a buy rating.Sti
IDEAYA Biosciences Is Maintained at Buy by Stifel
IDEAYA Biosciences Is Maintained at Buy by Stifel
IDEAYA Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/04/2024 62% Stifel $55 → $63 Maintains Buy 05/13/2024 18.28% Goldman Sachs $53 → $46 Maintains Buy 05/0
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long
72991267 : Glad I have some $Candel Therapeutics (CADL.US)$ after my disastrous SBFM.